-+ 0.00%
-+ 0.00%
-+ 0.00%

UBS Maintains Neutral on Pediatrix Medical Group, Raises Price Target to $16.5

Benzinga·08/14/2025 14:38:43
Listen to the news
UBS analyst A.J. Rice maintains Pediatrix Medical Group (NYSE:MD) with a Neutral and raises the price target from $16 to $16.5.